Verastem (VSTM) Current Leases (2019 - 2026)
Verastem's (VSTM) quarterly Current Leases came in at $494000.0 in Q1 2026, down 51.52% year-on-year from $1.0 million in Q1 2025, and down 7.66% quarter-over-quarter from $535000.0 in Q4 2025.
Verastem (VSTM) Current Leases (2019 - 2026) Analysis & Trends
Verastem's Current Leases history runs 8 years deep, the most recent figure standing at $494000.0 for Q1 2026.
- On a quarterly basis, Current Leases fell 51.52% year-over-year to $494000.0 in Q1 2026; TTM through Mar 2026 was $494000.0, a 51.52% decrease from a year earlier, with the FY2025 full-year figure at $535000.0, down 46.23% from the prior year.
- Current Leases retreated to $494000.0 in Q1 2026 per VSTM's latest filing, from $535000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.0 million in Q2 2025 and bottomed at $494000.0 in Q1 2026.
- The 5-year median for Current Leases is $829000.0 (2023), against an average of $834058.8.
- Across the five-year window, Current Leases increased 19.38% in 2022 and slumped 51.52% in 2026, its largest moves.
- Year by year, Current Leases stood at $794000.0 in 2022, then increased by 18.51% to $941000.0 in 2023, then gained by 5.74% to $995000.0 in 2024, then slumped by 46.23% to $535000.0 in 2025, then fell by 7.66% to $494000.0 in 2026.
- Per Business Quant, the three latest VSTM Current Leases figures stand at $494000.0 (Q1 2026), $535000.0 (Q4 2025), and $793000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 494,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 494,000.00 |
| Dec 31, 2025 | 535,000.00 |
| Sep 30, 2025 | 793,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 995,000.00 |
| Sep 30, 2024 | 780,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 981,000.00 |
| Dec 31, 2023 | 941,000.00 |
| Sep 30, 2023 | 902,000.00 |
| Jun 30, 2023 | 865,000.00 |
| Mar 31, 2023 | 829,000.00 |
| Dec 31, 2022 | 794,000.00 |
| Sep 30, 2022 | 761,000.00 |
| Jun 30, 2022 | 728,000.00 |
| Mar 31, 2022 | 696,000.00 |
| Dec 31, 2021 | 667,000.00 |
| Sep 30, 2021 | 638,000.00 |
| Jun 30, 2021 | 610,000.00 |